Imran Iqbal - 3 years ago
Oxford's Stories
Kainat Bashir - 3 years ago
ANALYSIS - Financial Incentives More Effective Than Mandates in Handli ..
Zaroon Ismail - 3 years ago
UK Regulator Confirms Government's Request to Assess Oxford/AstraZenec ..
Rayyan Hanif - 3 years ago
UK Government Dismisses Concern Over AstraZeneca's COVID-19 Vaccine Ef ..
News / Anas Khan - 3 years ago
AstraZeneca's Vaccine Dosing Error May Lead to Revision of Trials - Ep ..
AstraZeneca's error in the dosing regimen of its coronavirus vaccine, which showed higher efficacy results, though fortuitous, might lead to an overall revision of clinical trials, George Rutherford, a professor of epidemiology and biostatistics at the University of California-San Francisco, told Sputnik
News / Nasir Mahmood - 3 years ago
AstraZeneca Executive Says Vaccine Eligible for Approval Even With 62% ..
AstraZeneca's coronavirus vaccine will still be eligible for approval even if only the lower proven efficacy level is taken into account, Mene Pangalos, the UK pharmaceutical company's executive vice president, said in response to criticism prompted by the jab's controversial diverging clinical test results
Rayyan Hanif - 3 years ago
Latest on Coronavirus
News / Hafsa Jamal - 3 years ago
AstraZeneca Shares Continue to Drop Over Vaccine's Questionable Effica ..
Shares of UK pharmaceutical company AstraZeneca continue on a downward trend for a third day straight amid the vanishing confidence in the efficacy of its coronavirus vaccine, developed jointly with the University of Oxford
News / Nasir Mahmood - 3 years ago
AstraZeneca COVID-19 Vaccine 90% Effective Only Among Age Group Below ..
The COVID-19 vaccine developed by AstraZeneca in collaboration with Oxford showed 90 percent efficacy only among study participants below 55 years of age, US Operation Warp Speed Chief Advisor Moncef Slaoui told reporters
Rania Khalil - 3 years ago